Organovo Holdings, Inc. (NASDAQ: ONVO) shares are up 4% after the company announced a collaboration with the University of Virginia to develop 3D bioprinted tissues for volumetric muscle loss (VML) injury. In VML injuries, the muscle’s natural ability to regenerate cannot over power the severe damage, which results in lasting functional and cosmetic deficits. Currently, there are limited treatments offered for these patients. The research collaboration will be held at the laboratory of George J. Christ, Ph.D., professor of biomedical engineering and orthopaedic surgery at UVA. “Combining the expertise in muscle regeneration of Dr. Christ’s lab and University of Virginia with Organovo’s expertise in constructing human tissues is an important step towards helping patients and families who have been calling for solutions in volumetric muscle loss,” Eric David, M.D., J.D., Organovo’s chief strategy officer and executive VP of preclinical development, stated in the news release.
To view the full press release, visit: http://nnw.fm/RiDa9
About Organovo Holdings, Inc.
Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic applications. The company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic and other partners. Organovo’s 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. The company’s ExVive Human Liver and Kidney Tissues are used in toxicology and other preclinical drug testing. The company also actively conducts early research on specific tissues for therapeutic use in direct surgical applications. In addition to numerous scientific publications, the company’s technology has been featured in The Wall Street Journal, Time Magazine, The Economist, Forbes, and numerous other media outlets. Learn more at www.organovo.com.
NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer